ANTIGENIC ACTIVITY ASSAYS OF EXPERIMENTAL CONJUGATE VACCINES BASED ON SYNTHETIC OLIGOSACCHARIDE LIGANDS AND CRM197 CARRIER PROTEIN
So far, there is no effective treatment for a number of socially significant bacterial and fungal diseases. β-(1→3) glucans are polysaccharides consisting of glucose units linked together with β-(1→3)- glycoside bonds. They are principal components of the fungal cell wall including such dangerous no...
Guardado en:
Autores principales: | E. G. Bogomolova, O. A. Dodrovolskaya, E. A. Fedorova, A. M. Kondrashkina, N. N. Kolmakov, S. A. Ishchuk, I. V. Dukhovlinov, A. S. Simbirtsev |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
SPb RAACI
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f8febc2e283845ccb8de097f0d48d2b1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PRODUCTION OF RECOMBINANT PROTEIN CRM197 IN ESCHERICHIA COLI
por: I. V. Dukhovlinov, et al.
Publicado: (2015) -
A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study
por: An-Wen Xiong, et al.
Publicado: (2021) -
CRM AT THE HEART OF THE DIGITAL TRANSFORMATION
por: INTISSAR KARIM, et al.
Publicado: (2021) -
CRM System: the Role of Dynamic Capabilities in creating Innovation Capability
por: Cristiane Drebes Pedron, et al.
Publicado: (2018) -
DEVELOPMENT OF FUSION RECOMBINANT PROTEINS BASED ON VP6 AND VP8 OF HUMAN ROTAVIRUS A
por: I. V. Dukhovlinov, et al.
Publicado: (2014)